The deal highlights how genome interpretation remains a significant expense for many diagnostic labs, even as sequencing costs have fallen.
Lucid Genomics, Genetic Alliance Partner on…
The deal highlights how genome interpretation remains a significant expense for many diagnostic labs, even as sequencing costs have fallen.